OTC - ACTIVE INGREDIENT SECTION
glycerin
glycerin
water, arginine, carbomer, etc
skin protectant
1. If the following symptoms occur after product use, stop using the product immediately and consult a dermatologist (continuous use can exacerbate the symptoms).
1) Occurrence of red spots, swelling, itchiness, and other irritation
2) If the symptoms above occur after the application area is exposed to direct sunlight
2. Do not use on open wounds, eczema, and other irritations
3. Precaution for Storage and Handling
1) Close the lid after use
2) Keep out of reach of infants and children
3) Do not to store in a place with high/low temperature and exposed to direct sunlight
4. Use as avoiding eye areas.
Keep out of reach of children.
apply proper amount to the skin
external use only
| Class | Version | Type | Effective |
|---|---|---|---|
| GLYCERIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 72311-0003-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-cf98-f424-e053-dadaa90a57ce | 6dd4dbe0-aef3-5d6a-e053-2a91aa0aa106 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72311-0003-1 | Jena Cell VL Volume Lift | 50 mL in 1 BOTTLE | LIQUID | 50 | 1 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 72311-0003 | JENA CELL VL VOLUME LIFT (GLYCERIN) LIQUID [JENA INTERNATIONAL LTD] | 1 | Legacy NDC, 1 package rows | 20180604_6dd4dbe0-aef3-5d6a-e053-2a91aa0aa106.zip |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 72311-0003 | 72311-0003-1 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| WATER | 059QF0KO0R | IACT |
| GLYCERIN | PDC6A3C0OX | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 6dd4dbe0-aef4-5d6a-e053-2a91aa0aa106 | 6dd4dbe0-aef3-5d6a-e053-2a91aa0aa106 | 2018-06-04 | Warnings | 6dd4dbe0-aef4-5d6a-e053-2a91aa0aa106 6dd4dbe0-aef3-5d6a-e053-2a91aa0aa106 |
Adverse event summaries are temporarily unavailable. Other product information remains available.